ArticleJapanese journal of clinical oncology2025

Correction to: Impact of trastuzumab emtansine (T-DM1) on spleen volume in patients with HER2-positive metastatic breast cancer.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.